Table 1.
Group | No. of animals/group | Vector/buffer | Dose/animal | Ad5 priming | No. of survivors/no. of animals tested |
---|---|---|---|---|---|
1 | 12 | AdtPA83hu + AdmInhAhu | High dose | – | 12/12 |
2 | 12 | A195 buffer | None | – | 0/12 |
3 | 12 | AdtPA83hu + AdmInhAhu | High dose | + | 12/12 |
4 | 11b | AdtPA83hu + AdmInhAhu | Median dose | + | 11/11 |
5 | 12 | AdtPA83hu + AdmInhAhu | Low dose | + | 12/12 |
6 | 12 | AdmInhAhu | 108 IFU | – | 0/12 |
7 | 12 | A195 buffer | None | + | 0/12 |
8 | 12 | Naive control | None | – | 0/12 |
High dose, 108 IFU of AdtPA83hu/mouse plus 5.4 × 106 IFU of AdmInhAhu/mouse; median dose, 107 IFU of AdtPA83hu/mouse plus 5.4 × 105 IFU of AdmInhAhu/mouse; low dose, 106 IFU of AdtPA83hu/mouse plus 5.4 × 105 IFU of AdmInhAhu/mouse; none, no AdtPA83hu and AdmInhAhu treatment.
Lost one animal without replacement.